Last reviewed · How we verify
adenosine monophosphate
adenosine monophosphate is a Small molecule drug developed by Zhujiang Hospital. It is currently FDA-approved. Also known as: AMP.
Adenosine monophosphate, marketed by Zhujiang Hospital, holds a unique position in its therapeutic segment despite limited revenue data. The drug's key composition patent is set to expire in 2028, providing a period of market exclusivity and potential competitive advantage. However, the lack of detailed primary trial results and identified competitors poses a significant risk to its long-term market sustainability.
At a glance
| Generic name | adenosine monophosphate |
|---|---|
| Also known as | AMP |
| Sponsor | Zhujiang Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma (PHASE2)
- A Phase 1b Study of Adenylosuccinic Acid (ASA-001) for Adenylosuccinate Synthase 1 (ADSS1) Deficient Myopathy. (PHASE1)
- Effects of High Altitude on AMPK Activation
- Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer (PHASE2)
- Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture (NA)
- AWARE: Management of ADHD in Autism Spectrum Disorder (PHASE4)
- INSTI's For The Management of HIV-associated TB (PHASE2)
- Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- adenosine monophosphate CI brief — competitive landscape report
- adenosine monophosphate updates RSS · CI watch RSS
- Zhujiang Hospital portfolio CI
Frequently asked questions about adenosine monophosphate
What is adenosine monophosphate?
Who makes adenosine monophosphate?
Is adenosine monophosphate also known as anything else?
What development phase is adenosine monophosphate in?
Related
- Manufacturer: Zhujiang Hospital — full pipeline
- Also known as: AMP
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing